QCI Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-1,017
| Closed | -$45K | – | 163 |
|
2020
Q1 | $45K | Buy |
1,017
+45
| +5% | +$1.99K | ﹤0.01% | 241 |
|
2019
Q4 | $48K | Hold |
972
| – | – | ﹤0.01% | 264 |
|
2019
Q3 | $43K | Buy |
972
+12
| +1% | +$531 | ﹤0.01% | 276 |
|
2019
Q2 | $40K | Hold |
960
| – | – | ﹤0.01% | 302 |
|
2019
Q1 | $39K | Sell |
960
-67
| -7% | -$2.72K | ﹤0.01% | 294 |
|
2018
Q4 | $39K | Buy |
1,027
+52
| +5% | +$1.98K | ﹤0.01% | 285 |
|
2018
Q3 | $39K | Hold |
975
| – | – | ﹤0.01% | 306 |
|
2018
Q2 | $34K | Sell |
975
-180
| -16% | -$6.28K | ﹤0.01% | 289 |
|
2018
Q1 | $40K | Hold |
1,155
| – | – | ﹤0.01% | 277 |
|
2017
Q4 | $40K | Hold |
1,155
| – | – | ﹤0.01% | 276 |
|
2017
Q3 | $39K | Sell |
1,155
-1,280
| -53% | -$43.2K | ﹤0.01% | 247 |
|
2017
Q2 | $83K | Buy |
2,435
+240
| +11% | +$8.18K | 0.01% | 172 |
|
2017
Q1 | $68K | Buy |
2,195
+5
| +0.2% | +$155 | 0.01% | 184 |
|
2016
Q4 | $60K | Hold |
2,190
| – | – | 0.01% | 185 |
|
2016
Q3 | $72K | Buy |
2,190
+20
| +0.9% | +$658 | 0.01% | 173 |
|
2016
Q2 | $66K | Hold |
2,170
| – | – | 0.01% | 189 |
|
2016
Q1 | $61K | Sell |
2,170
-494
| -19% | -$13.9K | 0.01% | 186 |
|
2015
Q4 | $90K | Buy |
2,664
+494
| +23% | +$16.7K | 0.01% | 149 |
|
2015
Q3 | $69K | Hold |
2,170
| – | – | 0.01% | 180 |
|
2015
Q2 | $69K | Sell |
2,170
-280
| -11% | -$8.9K | 0.01% | 160 |
|
2015
Q1 | $84K | Buy |
2,450
+1,040
| +74% | +$35.7K | 0.01% | 147 |
|
2014
Q4 | $50K | Hold |
1,410
| – | – | 0.01% | 195 |
|
2014
Q3 | $50K | Hold |
1,410
| – | – | 0.01% | 200 |
|
2014
Q2 | $52K | Hold |
1,410
| – | – | 0.01% | 195 |
|
2014
Q1 | $46K | Hold |
1,410
| – | – | 0.01% | 202 |
|
2013
Q4 | $42K | Hold |
1,410
| – | – | 0.01% | 210 |
|
2013
Q3 | $37K | Hold |
1,410
| – | – | 0.01% | 209 |
|
2013
Q2 | $33K | Buy |
+1,410
| New | +$33K | 0.01% | 230 |
|